10 December 2018 - The pharmaceutical industry is calling on the government to urgently provide more detail on how it plans to ensure a continued supply of medicines should the UK leave the EU under a ‘no-deal’ scenario.

The move follows publication of an open letter by Health Secretary Matt Hancock touching on the government’s preparations in the event that an agreement is not finalised.

According to Hancock, the European Commission has made it clear that under a ‘no deal’ scenario it will impose ‘full third country controls’ on people and goods entering the EU from the UK, the impact of which would likely be felt most on the short straits crossings into Dover and Folkestone, potentially affecting medicines supply.

Read Pharma Times article